| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.23 | 5e-06 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.25 | 1e-05 |